Call for abstracts
Share your research with Europe's largest audience of applied and translational clinicians and researchers!

Submit an abstract for poster presentation at the 36^th ECNP Congress 2023 on or before 15 May 2023.

You will find all the information you need on the congress website, including videos to help you write the perfect abstract. If you have further questions, let us know.

Registration is open
You are welcome to join either in-person in Barcelona or virtually!
Take advantage of a lower in-person registration fee by registering on or before 15 May.
Register here

We also offer special fees for ECNP Members, Early Career Scientists (ECSs) and residents of a Country with a Developing Economy (CDE).

Programme is online
All scientific sessions confirmed so for at the 36^th ECNP Congress 2023 have been published!
The anchor of our programme are the Keynote Lecture and Plenary Lectures. View here our line-up so far.

Browse the preliminary programme

Join this meeting virtually by registering on or before 8 March 2023! All scientists, industry leaders, patient representatives and regulators interested in exploring this dynamic new area of emerging science and its research, treatment and regulatory horizons are invited to join this meeting virtually on 19-20 March 2023.
This means you will get access to the virtual platform where all sessions will be livestreamed.

Check the programme and register now.

In this podcast Ilse Graat, the Netherlands, interviews Kim Kuypers, the Netherlands, on her path towards psychedelics, discussing where this young research field stands and where it is heading, including new research on microdosing yet to be explored.

Find the podcast here, or on Spotify, iTunes or Buzzsprout.

Read the interview ‘The PRISM project: pointing the way to a more precise psychiatry’ with Hugh Marston, head of Global CNS Diseases at Boehringer Ingelheim and industry lead on this groundbreaking project. He discusses the industry perspective with ECNP press officer, Tom Parkhill.

PRISM 2 is a five-year research project under the aegis of the Innovative Medicines Initiative 2 and supported by ECNP.

AIMS-2-TRIALS is a landmark seven-year EU-funded project to improve the treatment prospects, with better diagnosis and new medicines, for the 5.5 million Europeans with autism. The newsletter features the latest project developments in this dynamic area of research, including recognising faces: microstates; how measuring brain activity can help tailor support for autistic people; how infants’ brain activity when seeing faces is written in their DNA; and much more...

AIMS-2-TRIALS is supported by ECNP.

To honour the research and achievements of outstanding neuroscientists FENS and its partner organisations invites nominations for the following prizes:

• ALBA-FKNE Diversity Prize 2023, in recognition of a scientist or group that has made outstanding contributions to promoting equality and diversity in brain sciences.
  Nomination extended deadline: 10 February 2023
  
  
• ALBA-Elsevier Award Lecture on Brain Sciences 2023, in recognition of research achievements of outstanding quality by an active scientist working at the frontiers of brain research.
  Nomination deadline: 3 March 2023
  
  
• Eric Kandel Young Neuroscientists Prize 2023, in recognition of outstanding work by young researchers in any field of neuroscience.
  Nomination deadline: 1 May 2023

ECNP congratulates Suzanne Dickson, ECNP Secretary, on her election as president of the European Brain Council.

If you would like to support the EBC and its mission, you are warmly invited to attend the first European Brain Foundation Fundraising Gala Dinner on 16 March 2023, in Brussels. For more about the Gala and to obtain a ticket, click here.